Patients stratified into inflammation-high subtypes were associated with high mortality, unmethylated MGMT promoter status, IDH wild-type status, 1p19q non-codeletion status, WHO III grade, and astrocytoma histology. The gene discussed is MGMT; the disease is astrocytoma (excluding glioblastoma).